Cell BioEngines LLC - Powering Cellular Medicine
About Us
Technology
Our Pipeline
Our Team
News
Careers
Cell BioEngines LLC - Powering Cellular Medicine
About Us
Technology
Our Pipeline
Our Team
News
Careers
More
  • About Us
  • Technology
  • Our Pipeline
  • Our Team
  • News
  • Careers
  • About Us
  • Technology
  • Our Pipeline
  • Our Team
  • News
  • Careers

Product Pipeline

Our business model allows us to pursue a broad range of cell and gene therapy product candidates in therapeutic areas of interest with high clinical and commercial potential.

CELL-BASED CANCER IMMUNOTHERAPY

At Cell BioEngines, we build a diverse portfolio of expanded stem cells and its derived immune cell-based therapies originated within our team, through out-licensing from some of the world's largest academic institutions or partnerships with pharma-biotech companies.


We are an innovative cellular medicine company focussed on generating meaningful value creation opportunities through our diversified pipeline with the potential to produce life-changing therapies for people in need.

HOW WE DO IT

Our Capabilities

  • Integrated scientific and market analytics
  • Strategy and business development
  • Executing transactions from licensing to M&A
  • Research and manufacturing operations
  • Financing strategy and capital markets
  • Strategic commercial partnerships

TECHNOLOGY PARTNER

Icahn School of Medicine at Mount Sinai

Product Pipeline

To democratize cellular medicine, we leverage our significant platform technology expertise to expand our product portfolio spanning several large market therapeutic areas. Our diversified product pipeline includes both, pre-clinical and clinical-stage candidates.

Partnering Opportunities


For more information on our business development opportunities, please reach out to us using the link provided.


LEARN MORE ABOUT PARTNERING

OUR INVESTORS

Copyright © 2024 Cell BioEngines, Inc - All Rights Reserved.